News

McKesson CFO Jeff Campbell steps down

BY Antoinette Alexander

SAN FRANCISCO — McKesson has announced that Jeffrey C. Campbell, EVP and CFO, will leave the company at the end of June to become the CFO of American Express.

Campbell has served McKesson as CFO since 2003, playing an instrumental role in extending the company’s leadership in healthcare services and information technology, the company stated.

“Jeff is a talented executive and we thank him for his tremendous contributions over the past decade,” stated John Hammergren, chairman and CEO of McKesson. “He has superbly guided McKesson’s financial functions during a period of steady growth and shareholder value creation, and he has developed a strong team of individuals who will continue leading our finance operations during this transition. We wish Jeff the greatest success in his future with American Express.”

Until Campbell’s permanent replacement has been named, Nigel A. Rees, VP and controller, will assume the role of interim CFO, effective June 28. A 12-year McKesson veteran, Rees previously served as SVP of finance at Adecco, SA, a global staffing and professional services company. He also has held senior finance leadership roles with Tandem Computers, International Microcomputer Software and Challenge Dairy Products.

“My time at McKesson has been an extraordinary experience, and I am delighted to be leaving the company in such great shape,” stated Campbell. “It has been a privilege to contribute to McKesson’s success and I believe that few organizations are better positioned to capitalize on the opportunities ahead in health care. After a decade of working with John and the team to build a world-class finance function, I am excited to begin a new chapter with American Express and help one of the world’s most respected financial services firms extend its track record of performance.”
 


Get connected and follow us on LinkedIn for the most in-depth coverage of drug store news. Join the conversation.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

News

FDA approves Plan B One-Step OTC switch

BY Alaric DeArment

SILVER SPRING, Md. — The Food and Drug Administration has approved a contraceptive pill for all women of childbearing potential without a prescription, the agency said.

The FDA said the new approval of Teva Women’s Health’s Plan B One-Step (levonorgestrel) was to comply with an April 5 federal court order to make emergency contraceptives containing levonorgestrel available over the counter without age or point-of-sale restrictions.

The pill is designed to reduce the odds of pregnancy after unprotected sex or failure of other contraceptives, such as condoms. The agency notified a U.S. District Court in New York of its intention to follow the court’s order to make such drugs available over the counter, and Teva was required to submit a regulatory application seeking approval of the pill as an OTC product. The drug was originally approved in 2009 without a prescription for girls and women aged 17 and older. In April of this year, that age threshold was lowered to 15, and the latest decision removes age requirements altogether.


Get connected and follow us on LinkedIn for the most in-depth coverage of drug store news. Join the conversation.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

News

Boots’ No7 Men skin care collection comes to Walgreens, Duane Reade

BY Antoinette Alexander

NEW YORK & DEERFIELD, Ill. — No7 Men skin care products, part of the U.K.’s skin care brand No7 created by Boots, is now available chainwide at Walgreens and Duane Reade stores.

The debut marks the first nationwide Boots product launch for Walgreens with Alliance Boots since the two companies formed a strategic partnership last summer to create a global pharmacy-led, health and wellbeing enterprise. No7 is known for its range of skin care products.


“We’re thrilled to introduce our No7 Men skin care products in the U.S. through our partnership with Walgreens,” stated Gordon Farquhar, managing director for Boots Retail USA. “We know that there is a huge interest and need for great skin care options for men, and No7 is a brand with a rich heritage and proven science. We see this as the beginning of a successful partnership with Walgreens and look forward to introducing even more products for men from No7.”



“With the launch of No7 Men in our stores, we look forward to working with Boots to provide our customers with differentiated products, making Walgreens their first choice for health and daily living,” added Mark Wagner, Walgreens president of Operations and Community Management. “These products, including the No7 Men Protect & Perfect Moisturiser with SPF, highlight our commitment to help our male customers get, stay and live well.” 



Shannon Curtin, divisional VP and GMM – beauty, personal care and seasonal, added, "No7 Men is an exciting opportunity to meet the expanding needs of our male customers. The daily regimen consists of cleansers, SPF moisturizers and anti-aging solutions. No7 Men is a wonderful addition to our male grooming product portfolio." 


The full range of products, now available, includes:

  • No7 Men Protect & Perfect Intense Moisturiser with SPF 15 ($22.99)
  • No7 Men Protect & Perfect Intense Serum ($24.99)
  • No7 Men Energising Face Wash ($7.99)
  • No7 Men Energising Face Scrub ($8.99)
  • No7 Men Energising Hair & Body Wash ($7.99)
  • No7 Men Rapid Revival Eye Roll On ($16.99)

The products also can be purchased on Walgreens.com, drugstore.com and US.Boots.com.
 


Get connected and follow us on LinkedIn for the most in-depth coverage of drug store news. Join the conversation.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES